Supporting Publication

  • 2023

    Discovery of a novel NAMPT inhibitor that selectively
    targets NAPRT-deficient EMT-subtype cancer cells and
    alleviates chemotherapy-induced peripheral
    neuropathy (2023)

  • 2022
    Cancer Communications

    Snail acetylation by autophagy-derived
    acetyl-coenzyme A promotes invasion and metastasis
    of KRAS-LKB1 co-mutated lung cancer cells (2022)

  • 2020
    Nature Communications

    Integrated pharmaco-proteogenomics defines two
    subgroups in isocitrate dehydrogenase wild-type
    glioblastoma with prognostic and therapeutic
    opportunities (2020)

  • 2018

    Selective cytotoxicity of the NAMPT inhibitor FK866
    toward gastric cancer cells with markers of the
    epithelial-mesenchymal transition, due to loss of NAPRT.


    Chemistry-first approach for nomination of
    personalized treatment in lung cancer